Clark Eliana (CIK 1914448) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy NTLA (7,353 shares), Sell NTLA (607 shares), Sell NTLA (9,515 shares), Sell NTLA (1,022 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Technical Officer | Buy | 7,353 | $0 |
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Technical Officer | Sell | 607 | $8,364 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Technical Officer | Sell | 9,515 | $87,633 |
| 2025-07-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Technical Officer | Sell | 1,022 | $10,036 |
来源：SEC Form 4 申报文件 · 截至 2026-03-03